DexCom
DXCM
#891
Rank
NZ$44.51 B
Marketcap
NZ$113.51
Share price
0.20%
Change (1 day)
-15.48%
Change (1 year)

DexCom (DXCM) - P/B ratio

P/B ratio as of December 2025 : 9.44

According to DexCom's latest financial reports the company has a price-to-book ratio of 5.69836.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

DexCom - P/B ratio (from 2005 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-3114.9155.64%
2023-12-315.83-72.03%
2022-12-3120.8-18.19%
2021-12-3125.531.11%
2020-12-3119.4-14.38%
2019-12-3122.739.66%
2018-12-3116.336.69%
2017-12-3111.9-33.12%
2016-12-3117.8-41.22%
2015-12-3130.2-0.34%
2014-12-3130.4-0.57%
2013-12-3130.5148.86%
2012-12-3112.3103.94%
2011-12-316.01-56.71%
2010-12-3113.9-168.96%
2009-12-31-20.1376.46%
2008-12-31-4.23-111.9%
2007-12-3135.5712.89%
2006-12-314.37-42.54%
2005-12-317.61

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Edwards Lifesciences
EW
4.85-48.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
2.13-77.41%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical
WST
6.34-32.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
10.6 12.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
2.70-71.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Abbott Laboratories
ABT
4.15-56.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
6.13-35.09%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
0.9060-90.40%๐Ÿ‡บ๐Ÿ‡ธ USA